Rigel to Participate in Upcoming September Investor Conferences
Rigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major investor conferences this September 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Rigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major investor conferences this September 2025.
The company's leadership, including CEO Raul Rodriguez and CFO Dean Schorno, will attend the Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, and H.C. Wainwright Global Investment Conference. Company presentations are scheduled at Cantor (September 3, 8:35 a.m. ET) and H.C. Wainwright (September 9, 1:30 p.m. ET), with webcasts available through Rigel's investor relations website.
Details
News Market Reaction – RIGL
On Aug 26, the day this news came out, RIGL closed 2.16% above the previous close.
Data tracked by StockTitan Argus for the Aug 26 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Citi's 2025 Biopharma Back to School Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Tuesday, September 2. - Cantor Global Healthcare Conference 2025 in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Wednesday, September 3, at 8:35 a.m. ET. - 2025 Wells Fargo Healthcare Conference in
Boston, MA
Rigel will participate in one-on-one meetings on Thursday, September 4. - H.C. Wainwright 27th Annual Global Investment Conference in
New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 9, at 1:30 p.m. ET.
To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright Conference presentations, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-302538238.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.